Sanara MedTech (SMTI) Accumulated Expenses (2010 - 2026)

Sanara MedTech's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• Quarterly Accumulated Expenses rose 10.6% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 10.6% YoY) and the FY2025 annual result came in at $11.8 million, up 16.83% from the prior year.
• Accumulated Expenses was $9.1 million for Q1 2026 at Sanara MedTech, down from $11.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $11.8 million in Q4 2025 and bottomed at $3.1 million in Q1 2022.
• A 5-year average of $7.6 million and a median of $7.7 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 647.29% — and 2023, when it dropped 3.89%.
• Sanara MedTech's Accumulated Expenses stood at $7.8 million in 2022, then declined by 1.05% to $7.7 million in 2023, then surged by 31.37% to $10.1 million in 2024, then increased by 16.83% to $11.8 million in 2025, then dropped by 22.91% to $9.1 million in 2026.
• Business Quant data shows SMTI's Accumulated Expenses at $9.1 million in Q1 2026, $11.8 million in Q4 2025, and $10.9 million in Q3 2025.